38 development-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"Various" Postdoctoral positions at Duke University
Sort by
Refine Your Search
-
Listed
-
Field
-
for postdoctoral fellows. We are seeking highly motivated candidates to join our research program in regeneration genomics. Our laboratory develops and applies cutting-edge genomics and proteomics technologies
-
federally funded studies while developing an independent program of scholarship aligned with the HEEAT Lab mission. Working closely with community partners, health systems, policymakers, and interdisciplinary
-
leading experts in autism research, computer vision, machine learning, psychiatry, and developmental science to develop innovative technologies that improve how caregiver-child interactions and
-
join a highly collaborative, interdisciplinary research environment focused on developing and applying cutting-edge machine learning and deep learning methods to abdominal imaging. Working alongside
-
new NIH-funded Center for Excellence in Multiscale Immune Systems Modeling . This position focuses on the development, calibration, and analysis of multiscale agent-based models (ABMs) and differential
-
researchers, you will contribute to groundbreaking studies focused on juvenile dermatomyositis (JDM) and the role of type I interferons in disease development and progression. Your work will help bridge
-
. The Quantitative Imaging and Analysis Laboratory in the Department of Radiology at Duke University is seeking a Postdoctoral Associate to join our team. In this role, you will work on the development
-
, learning, well-being, social experiences, and decision-making. HARP is developing a longitudinal multimodal research resource to study human-AI interaction and its impacts using student-informed, privacy
-
to understanding the fundamental mechanisms that drive cancer development, treatment response, and therapeutic resistance. By combining cutting-edge molecular biology, functional genomics, and translational research
-
on identifying and validating surrogate endpoints for overall survival using data from cancer clinical trials and patient registries, developing prognostic models of clinical outcomes in cancer, and conducting